Both cisplatin and HDAC inhibitors can modulate cell death mechanisms, e.g., caspases, in cancer cell lines [40, 41], but the action of the platinum(II) drug and PBA together to activate apoptotic pathways in non-cancerous tissue has not been previously analyzed. Here, HDAC9 is linked to cancer.